BPG is committed to discovery and dissemination of knowledge
Articles in Press
5/26/2026 8:31:19 AM | Browse: 3 | Download: 0
Publication Name World Journal of Hepatology
Manuscript ID 119837
Country United States
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Phase-dependent interpretation of quantitative hepatitis B surface antigen and hepatocellular carcinoma risk in chronic hepatitis B infection
Manuscript Source Unsolicited Manuscript
All Author List Yazan Omari and Mohammad Almeqdadi
Funding Agency and Grant Number
Corresponding Author Yazan Omari, MD, Internal Medicine, Henry Ford Health, 16001 West 9 Mile Road, Southfield, MI 48075, United States. yazanomari12@gmail.com
Key Words Quantitative hepatitis B surface antigen; Hepatitis B; Hepatocellular carcinoma; Disease phase; Hepatitis B virus integration; Risk stratification; Phase-dependent interpretation
Core Tip Quantitative hepatitis B surface antigen can serve as a complementary predictor of development of hepatocellular carcinoma among chronic hepatitis B patients. However, its interpretation is largely dependent on the phase of chronic hepatitis B at which it was measured. This phase-dependence arise from inherent differences in the pathophysiology of viral replication (from covalently closed circular DNA in early stages to integration-driven antigen production in later stages) and evolving host immune control. Clinically, quantitative hepatitis B surface antigen offers the most predictive value in hepatitis B e antigen negative patients with low viremia (< 2000 IU/mL). In this group, persistently elevated marker level (> 1000 IU/mL) can identify patients with significantly increased risk of developing hepatocellular carcinoma who warrant closer monitoring or earlier treatment discussion. Recognizing this in context is essential for appropriate clinical use.
Citation Omari Y, Almeqdadi M. Phase-dependent interpretation of quantitative hepatitis B surface antigen and hepatocellular carcinoma risk in chronic hepatitis B infection. World J Hepatol 2026; In press
Received
2026-02-07 03:26
Peer-Review Started
2026-02-07 03:27
First Decision by Editorial Office Director
2026-02-28 06:53
Return for Revision
2026-02-28 06:53
Revised
2026-03-17 00:32
Publication Fee Transferred
2026-04-08 17:02
Second Decision by Editor
2026-05-26 02:39
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-05-26 08:31
Articles in Press
2026-05-26 08:31
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5182 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com